glp-1 cause muscle loss Study finds receptor agonists target fat over for weight Weighing the risk of GLP-1

Description

For comparison, the average bariatric surgery patient loses about 25-to-35% of their body weight

The drug enters your bloodstream through subcutaneous tissue, not through the digestive tract

The downstream health savings from that magnitude of weight loss include: | Potential Savings | Annual Value | |-------------------|-------------| | Reduced diabetes risk/medications -- see [GLP-1 comparison chart](/guides/glp1-medications-comparison-chart-guide) for all options | $2,000-6,000 | | Blood pressure medication reduction | $600-1,800 | | Sleep apnea treatment reduction | $1,200-3,600 | | Avoided bariatric surgery | $20,000-35,000 (one-time) | | Reduced joint replacement risk | $30,000-50,000 (lifetime) | Against a first-year cost of $3,000-5,500 for compounded retatrutide, the financial case is strong for patients who respond well

The use of GLP-1 agonists in the management of cutaneous disease

Researchers meta-analyzed 20 large published randomized controlled studies with 83,288 patients and found a very small but not statistically significant increase in NAION in those treated with GLP-1s